Published in Scand J Haematol Suppl on January 01, 1984
Detection of hepatitis-B surface antigen in blood and blood products dried on filter paper. Lancet (1978) 2.48
Supervised patient-management of hemophilia. A study of 45 patients with hemophilia A and B. Ann Intern Med (1973) 1.46
Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation. Bone Marrow Transplant (2000) 1.42
The prevalence of hepatitis B surface antigen and its antibody in blood donors and high risk groups in Iran. Vox Sang (1979) 1.31
Genes and people in the Caspian Littoral: a population genetic study in Northern Iran. Am J Phys Anthropol (1977) 1.06
Congenital deficiency of factor 13 (fibrin-stabilizing factor): Report of a case and review of the literature. Am J Med (1967) 0.97
Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility. Br J Haematol (1970) 0.93
Validation of the determination of deltaF508 mutations of the cystic fibrosis gene in over 11 000 mouthwashes. Hum Genet (1996) 0.91
Isolation of fungi from housefly (Musca domestica L.) at Slaughter House and Hospital in Sanandaj, Iran. J Prev Med Hyg (2012) 0.91
Hypertension secondary to renin-secreting juxtaglomerular cell tumor: case report and review of 38 cases. Pediatr Nephrol (1993) 0.86
Initial events in radiation-induced atheromatosis. II. Damage to intimal cells. Strahlentherapie (1978) 0.86
Replacement fluid in plasma exchange. Lancet (1980) 0.84
Heterogeneity of von Willebrand's disease: study of 40 Iranian cases. Br J Haematol (1977) 0.83
Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes. Eur J Cancer (1994) 0.83
Use of aspirin or acetaminophen in hemophilia. N Engl J Med (1970) 0.83
Aspirin as an antiplatelet agent: template bleeding time as a monitor of therapy. Am J Clin Pathol (1973) 0.82
High-yield method of production of freeze-dried purified factor VIII by blood banks. Lancet (1981) 0.82
Comparison of apheresis and other methods for separation and purification of hemopoietic stem cells: initial experience with a blood buffy coat model for the use of autologous bone marrow transplantation. Int J Artif Organs (1984) 0.81
Hepatitis C virus antibody positive blood donors. Gut (1993) 0.81
Weekly rotation of blood inventory--a system for supplying small hospitals. Transfusion (1980) 0.80
A novel alanine or threonine 789 to proline mutation causing type 2N von Willebrand's disease when inherited homozygously or heterozygously with arginine 854 to glutamine mutation. Haemophilia (2010) 0.80
How to deal with medical and social aspects of bleeding disorders--preparing women and the family in developing countries. Haemophilia (2011) 0.80
Subacute sclerosing panencephalitis: clinical and immunologic study of 23 patients. Neurology (1981) 0.79
Professional and voluntary blood: a preliminary study in Iran. Vox Sang (1978) 0.79
Heparin and factor VIII. Scand J Haematol Suppl (1984) 0.79
Hematologic aspects of cardiotomy suction in cardiac operations. J Thorac Cardiovasc Surg (1980) 0.79
A case report of post-transfusion hepatitis A. J Med Virol (1982) 0.79
The lower third molar and antiphlogistics. Int J Oral Surg (1982) 0.79
Saponin, an inhibitory agent of carbon dioxide production by white cells: its use in the microbiologic examination of blood components in an automated bacterial culture system. Transfusion (1998) 0.79
Abruptio placentae, disseminated intravascular coagulation and the use of heparin: a must? Bibl Anat (1973) 0.79
XI. The hereditary blood factors of the Kurds of Iran. Philos Trans R Soc Lond B Biol Sci (1973) 0.79
Cancer of the male breast. Am Surg (1994) 0.78
Haemovigilance systems. Vox Sang (1999) 0.78
Deficiency of the second complement component association with the HLA haplotype A10, B18 in a normal population. Ann Rheum Dis (1982) 0.78
Histocompatibility antigens (HLA) in rheumatic diseases in Iran. J Rheumatol Suppl (1977) 0.78
Small-pool high-yield factor VIII production. Crit Rev Clin Lab Sci (1986) 0.78
HLA AW19, B12 in immunoproliferative small intestinal disease. Gut (1979) 0.78
Identification of 123 previously unreported mutations in the F8 gene of Iranian patients with haemophilia A. Haemophilia (2011) 0.78
Seven novel point mutations in the F11 gene in Iranian FXI-deficient patients. Haemophilia (2007) 0.78
Improved hemocompatibility in open heart surgery. Trans Am Soc Artif Intern Organs (1978) 0.77
Identification of intron 1 and 22 inversion mutations in the factor VIII gene of 124 Iranian families with severe haemophilia A. Haemophilia (2004) 0.77
Identification of a homozygous Cys410Ser mutation in the von Willebrand factor D2 domain causing type 2A(IIC) von Willebrand disease phenotype in an Iranian patient. Haemophilia (2013) 0.77
Prevention of vessel wall damage in experimental irradiation. Bibl Anat (1973) 0.77
Inhibition of thymidine uptake by staphylococci, a new method for the investigation of phagocytosis. J Immunol Methods (1976) 0.77
Prevalence of delta F508 cystic fibrosis carriers in The Netherlands: logistic regression on sex, age, region of residence and number of offspring. Hum Genet (1997) 0.77
High frequency of Ina antigen among Iranians and Arabs. Hum Hered (1980) 0.77
In vitro evaluation of a high-efficiency leukocyte adherence filter. Ann Hematol (1991) 0.76
Factor XIII assay by an isotope method. II. Heparin inhibition of factor XIII activation. Thromb Diath Haemorrh (1970) 0.76
Supply and need of factor VIII concentrates. Haematologia (Budap) (1983) 0.76
The concentration of plasma fibronectin in burns patients treated with fresh frozen plasma or plasma protein fraction. Resuscitation (1984) 0.76
In vitro suppression of lymphocyte blastogenic response to mitogen and antigen by Leishmania tropica. Clin Exp Immunol (1978) 0.75
Gelatin particle agglutination assay as an auxiliary confirmation test for HIV-1 antibodies. Med Lab Sci (1990) 0.75
Histocompatibility antigens (HLA) in multiple sclerosis in Iran. J Neurol Neurosurg Psychiatry (1978) 0.75
Prophylaxis in hemophilia. Bibl Haematol (1970) 0.75
Immunoproliferative small intestinal disease and primary small intestinal lymphoma. Relation to alpha chain protein. Cancer (1985) 0.75
Treatment of hemarthrosis in hemophilia. N Engl J Med (1970) 0.75
[The use of blood and blood products in total hip arthroplasty in 31 European hospitals, 1990/'91]. Ned Tijdschr Geneeskd (1996) 0.75
Transfusion-associated graft-versus-host disease: current concepts and future trends. Transfus Sci (1995) 0.75
Letter: HB Ag Y-subtypes in Iran. N Engl J Med (1974) 0.75
Screening for anti-tetanus toxin antibodies in Iran. Rev Fr Transfus Immunohematol (1978) 0.75
Letter: Use of cryoprecipitate. N Engl J Med (1976) 0.75
Aspirin: a new nightmare for blood bankers. N Engl J Med (1972) 0.75
Preparation of leukocyte-poor platelet concentrates via a short, hard spin of a pool of buffy coats. Vox Sang (2000) 0.75
Factor VIII:C assay: influence of buffer components used in immunoaffinity chromatography for purification of factor VIII/von Willebrand factor. Thromb Res (1994) 0.75
Effects of peripheral stem cell or bone marrow reinfusion on peripheral serotonin metabolism. Bone Marrow Transplant (1999) 0.75
Haemoglobin Avicenna (beta 47 (CD6) Asp replaced by Ala). A new abnormal haemoglobin. Biochim Biophys Acta (1979) 0.75
In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation. Ann Hematol (2002) 0.75
The influence of tranexamic acid on thrombocytopenia caused by artificial surfaces. Trans Am Soc Artif Intern Organs (1974) 0.75
Cellular and plasma-associated phagocytic defects amongst Iranian blood donors. Vox Sang (1978) 0.75
A study of cell-mediated immunity and histocompatibility antigens in leprosy patients in Iran. Int J Lepr Other Mycobact Dis (1978) 0.75
Body composition and spontaneous growth hormone secretion in normal short stature children. J Clin Endocrinol Metab (1994) 0.75
Preliminary experience with the Groupamatic 360 C en Iran. Rev Fr Transfus Immunohematol (1978) 0.75
Two new haemoglobins: haemoglobin Perspolis (alpha 64 (E13) Asp leads to Tyr) and haemoglobin J-Kurosh (alpha 19 (AB) Ala leads to Asp). Biochim Biophys Acta (1976) 0.75
Neonatal exchange transfusion: present status. Clin Pediatr (Phila) (1968) 0.75
Hemoglobin Osu-Christiansborg (beta52 (D3) Aspyield Asn) in an Iranian family. Hemoglobin (1978) 0.75
[Study of the action of immunodepressive agents using the leukocyte migration test]. Acta Med Iran (1978) 0.75
Western blotting for HIV-antibody confirmation in blood donors: an improved approach by recombinant immunoblots. Transfus Med (1992) 0.75
Clinical outcome of interferon and ribavirin combination treatment in hepatitis C virus infected patients with congenital bleeding disorders in Iran. Haemophilia (2009) 0.75
Financial aspects of hemophilia care. Scand J Haematol Suppl (1984) 0.75
Evaluation of elutriated single donor platelets collected and stored in a closed system. J Clin Apher (1992) 0.75
[Subspecialty blood transfusion medicine]. Ned Tijdschr Geneeskd (1998) 0.75
Iliac fossa mass syndrome in hemophilia. JAMA (1970) 0.75
Hemophiliacs at summer camp. JAMA (1970) 0.75
Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue. Ann Hematol (1992) 0.75
Cell-mediated immunity in professional and voluntary blood donors. Vox Sang (1978) 0.75
Preliminary results of transfer factor therapy of persistant cutaneous leishmania infection. Clin Immunol Immunopathol (1979) 0.75
Preparation and storage of "leukocyte-depleted single donor" platelet concentrate: a step forward in effective haemotherapy. J Clin Apher (1991) 0.75
Worldwide supply of blood and blood products. World J Surg (1987) 0.75
Plateletpheresis donor safety, predonation platelet levels, and mobilized platelets. Transfusion (1980) 0.75
A little freedom for the hemophiliac. N Engl J Med (1970) 0.75
Specificity of transfer factor. In vitro lymphoblast transformation of peripheral lymphocytes to Leishmania major antigen in the presence of transfer factor. Scand J Immunol (1977) 0.75
Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method. Platelets (2011) 0.75
Combined HIV-1/2 assay kits. Lancet (1991) 0.75
Variable leukocyte composition of red blood cell concentrates prepared in top-bottom systems: possible implications for pre-transplant blood transfusion. Vox Sang (2000) 0.75
Hemoglobin G Saskatoon in association with PNH in an Iranian soldier. Hemoglobin (1981) 0.75
Surgery in congenital disorders of blood coagulation. Surg Gynecol Obstet (1966) 0.75
Hemophilia centers. JAMA (1979) 0.75
Mitogen-induced suppressor T cell activity in the in vitro cellular immune response. J Immunol Methods (1979) 0.75